0001810011-26-000003.txt : 20260814 0001810011-26-000003.hdr.sgml : 20260814 20260814095945 ACCESSION NUMBER: 0001810011-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260814 DATE AS OF CHANGE: 20260814 EFFECTIVENESS DATE: 20260814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Strella Biotechnology, Inc. CENTRAL INDEX KEY: 0001810011 ORGANIZATION NAME: EIN: 842608365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-594250 FILM NUMBER: 261276987 BUSINESS ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE CITY: PHILADELPHIA STATE: PA ZIP: 19146 BUSINESS PHONE: 703-909-4543 MAIL ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE CITY: PHILADELPHIA STATE: PA ZIP: 19146 D 1 primary_doc.xml X0708 D LIVE 0001810011 Strella Biotechnology, Inc. 1601 2nd Ave, STE 575 Seattle WA WASHINGTON 98101 703-909-4543 DELAWARE None None Corporation true Katherine Sizov 1601 2nd Ave, STE 575 Seattle WA WASHINGTON 98101 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2026-06-29 false true true false 0 3250000 1761591 1488409 false 35 0 0 200000 false Strella Biotechnology, Inc. Katherine Kunde Katherine Kunde by POA from Katherine Sizov, CEO of Strella Biotechnology 2026-08-14